Reference
Cooper S, et al. How should we assess the clinical and cost effectiveness of histology independent cancer drugs? BMJ 2020: l6435, No. 368, 2 Jan 2020. Available from: URL: https://doi.org/10.1136/bmj.l6435
Rights and permissions
About this article
Cite this article
Health technology assessments on histology-independent cancer drugs. PharmacoEcon Outcomes News 844, 1 (2020). https://doi.org/10.1007/s40274-020-6464-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6464-7